The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in revenue , its patent expiration created a wave of lower-priced alternatives , significantly impacting its position . While certain firms may seek to capitalize on similar conditions , the pre